Atlas Trials

Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Clinical trial NCT04648020 · TERMINATED

Trial details

NCT number
NCT04648020
Sponsor
Monopar Therapeutics
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chemoradiotherapy-Induced Severe Oral Mucositis
Start date
2021-02-11
Primary completion
2023-05-14
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.